• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation.

作者信息

Gavriilaki Eleni, Sakellari Ioanna, Chatzikonstantinou Thomas, Mallouri Despina, Batsis Ioannis, Vardi Anna, Bousiou Zoi, Koravou Eudoxia-Evaggelia, Masmanidou Marianna, Touloumenidou Tasoula, Papalexandri Apostolia, Athanasiadou Anastasia, Yannaki Evangelia, Anagnostopoulos Achilles

机构信息

Hematology Department, Bone Marrow Transplantation Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.

出版信息

Hemasphere. 2020 Dec 9;5(1):e487. doi: 10.1097/HS9.0000000000000487. eCollection 2021 Jan.

DOI:10.1097/HS9.0000000000000487
PMID:33324949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7732269/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7d3/7732269/fd9bb7126eb8/hs9-5-e487-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7d3/7732269/fd9bb7126eb8/hs9-5-e487-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7d3/7732269/fd9bb7126eb8/hs9-5-e487-g001.jpg

相似文献

1
Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation.内皮细胞与补体激活作为成人异基因造血细胞移植生存的预测指标
Hemasphere. 2020 Dec 9;5(1):e487. doi: 10.1097/HS9.0000000000000487. eCollection 2021 Jan.
2
Endothelial-like vascular progenitor cells (VPCs) from allogeneic and autologous donors: mobilization features distinct from hematopoietic progenitors.来自异体和自体供体的内皮样血管祖细胞（VPCs）：动员特征与造血祖细胞不同。
Biol Blood Marrow Transplant. 2007 Apr;13(4):433-9. doi: 10.1016/j.bbmt.2006.11.016. Epub 2007 Feb 15.
3
Refinement of the Glasgow Prognostic Score as a pre-transplant risk assessment for allogeneic hematopoietic cell transplantation.优化格拉斯哥预后评分作为异基因造血细胞移植的移植前风险评估指标。
Int J Hematol. 2018 Sep;108(3):282-289. doi: 10.1007/s12185-018-2463-x. Epub 2018 May 9.
4
Vascular endothelial growth factor and activin-a serum levels following allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后血管内皮生长因子和激活素A的血清水平
Biol Blood Marrow Transplant. 2007 Aug;13(8):942-7. doi: 10.1016/j.bbmt.2007.04.007.
5
Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD.血栓性微血管病和移植物抗宿主病中的循环双链DNA、内皮损伤及补体激活
Blood. 2017 Sep 7;130(10):1259-1266. doi: 10.1182/blood-2017-05-782870. Epub 2017 Jul 13.
6
Nonfluorodeoxyglucose-Avid Persistent Splenomegaly at Time of Transplantation Delays Neutrophil and Platelets Engraftment without Affecting Survival in Patients with Lymphomas Undergoing Allogeneic Hematopoietic Cell Transplantation.移植时非氟脱氧葡萄糖摄取持续存在的脾肿大延迟中性粒细胞和血小板植入，而不影响接受异基因造血细胞移植的淋巴瘤患者的生存。
Biol Blood Marrow Transplant. 2016 Dec;22(12):2201-2207. doi: 10.1016/j.bbmt.2016.09.014. Epub 2016 Sep 19.
7
Endothelial and Circulating Progenitor Cells in Hematological Diseases and Allogeneic Hematopoietic Stem Cell Transplantation.血液系统疾病及异基因造血干细胞移植中的内皮祖细胞和循环祖细胞
Curr Med Chem. 2018;25(35):4535-4544. doi: 10.2174/0929867324666171012110244.
8
The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms.造血干细胞移植后促成内皮细胞活化和损伤的可溶性因子释放并不局限于异基因移植情况，且涉及多种致病机制。
Biol Blood Marrow Transplant. 2009 May;15(5):537-46. doi: 10.1016/j.bbmt.2009.01.013.
9
Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma.自体-异体造血干细胞移植序贯治疗多发性骨髓瘤的长期随访。
Haematologica. 2019 Feb;104(2):380-391. doi: 10.3324/haematol.2018.200253. Epub 2018 Sep 27.
10
Association Between Low Plasma Level of Citrulline Before Allogeneic Hematopoietic Cell Transplantation and Severe Gastrointestinal Graft vs Host Disease.异基因造血细胞移植前血浆瓜氨酸水平低与严重胃肠道移植物抗宿主病的关系。
Clin Gastroenterol Hepatol. 2018 Jun;16(6):908-917.e2. doi: 10.1016/j.cgh.2017.12.024. Epub 2017 Dec 16.

引用本文的文献

1
Endothelial Injury Following CAR-T Cell Immunotherapy for Hematological Malignancies.血液系统恶性肿瘤的CAR-T细胞免疫治疗后的内皮损伤
Cancers (Basel). 2025 Sep 1;17(17):2876. doi: 10.3390/cancers17172876.
2
EASIX and m-EASIX predict severe cytokine release syndrome and overall survival after CAR T-cell therapy.EASIX和m-EASIX可预测CAR T细胞治疗后的严重细胞因子释放综合征和总生存期。
Blood Vessel Thromb Hemost. 2024 Aug 21;1(4):100025. doi: 10.1016/j.bvth.2024.100025. eCollection 2024 Dec.
3
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), Growth Differentiation Factor-15 (GDF-15), and Soluble C5b-9 (sC5b-9) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell Recipients.

本文引用的文献

1
Complementopathies and precision medicine.补体系统相关疾病与精准医学
J Clin Invest. 2020 May 1;130(5):2152-2163. doi: 10.1172/JCI136094.
2
Interferon-complement loop in transplant-associated thrombotic microangiopathy.移植相关性血栓性微血管病中的干扰素-补体循环。
Blood Adv. 2020 Mar 24;4(6):1166-1177. doi: 10.1182/bloodadvances.2020001515.
3
Pretransplant Genetic Susceptibility: Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy.移植前遗传易感性：移植相关性血栓性微血管病中的临床相关性。
可溶性尿激酶型纤溶酶原激活物受体 (suPAR)、生长分化因子 15 (GDF-15) 和可溶性 C5b-9 (sC5b-9) 水平与 CAR-T 细胞受者的内皮损伤指标显著相关。
Int J Mol Sci. 2024 Oct 14;25(20):11028. doi: 10.3390/ijms252011028.
4
Endothelial Activation and Stress Index (EASIX) in coronary artery disease: promising biomarker or oversimplified measure?冠状动脉疾病中的内皮激活与应激指数（EASIX）：是有前景的生物标志物还是过于简化的指标？
Clin Res Cardiol. 2024 Dec;113(12):1773-1774. doi: 10.1007/s00392-024-02565-5. Epub 2024 Oct 23.
5
Genetic Susceptibility in Endothelial Injury Syndromes after Hematopoietic Cell Transplantation and Other Cellular Therapies: Climbing a Steep Hill.造血细胞移植及其他细胞治疗后内皮损伤综合征中的遗传易感性：艰难前行。
Curr Issues Mol Biol. 2024 May 15;46(5):4787-4802. doi: 10.3390/cimb46050288.
6
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience.纳武利尤单抗在儿童和成人移植相关血栓性微血管病患者中的安全性和疗效：真实世界经验。
Bone Marrow Transplant. 2024 Aug;59(8):1161-1168. doi: 10.1038/s41409-024-02305-3. Epub 2024 May 21.
7
Posterior reversible encephalopathy syndrome post stem cell transplantation in sickle cell disease: case series and literature review.镰状细胞病干细胞移植后可逆性后部脑病综合征：病例系列及文献综述
Front Med (Lausanne). 2024 May 1;11:1330688. doi: 10.3389/fmed.2024.1330688. eCollection 2024.
8
Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy?移植物抗宿主病：生物标志物能否辅助鉴别诊断、预后评估及治疗策略制定？
Pharmaceuticals (Basel). 2024 Feb 26;17(3):298. doi: 10.3390/ph17030298.
9
The critical role of endothelial cell in the toxicity associated with chimeric antigen receptor T cell therapy and intervention strategies.嵌合抗原受体 T 细胞治疗相关毒性的内皮细胞关键作用及干预策略。
Ann Hematol. 2024 Jul;103(7):2197-2206. doi: 10.1007/s00277-024-05640-z. Epub 2024 Feb 8.
10
High-dose systemic adeno-associated virus vector administration causes liver and sinusoidal endothelial cell injury.高剂量全身腺相关病毒载体给药可导致肝脏和窦内皮细胞损伤。
Mol Ther. 2024 Apr 3;32(4):952-968. doi: 10.1016/j.ymthe.2024.02.002. Epub 2024 Feb 6.
Thromb Haemost. 2020 Apr;120(4):638-646. doi: 10.1055/s-0040-1702225. Epub 2020 Mar 4.
4
Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation.入院时内皮细胞激活和应激指数（EASIX）可预测异基因造血干细胞移植受者的液体超负荷。
Biol Blood Marrow Transplant. 2020 May;26(5):1013-1020. doi: 10.1016/j.bbmt.2020.01.028. Epub 2020 Feb 9.
5
Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab.补体阻断治疗 TA-TMA：依库珠单抗治疗的大型儿科队列中获得的经验教训。
Blood. 2020 Mar 26;135(13):1049-1057. doi: 10.1182/blood.2019004218.
6
EASIX and mortality after allogeneic stem cell transplantation.异体造血干细胞移植后的EASIX与死亡率
Bone Marrow Transplant. 2020 Mar;55(3):553-561. doi: 10.1038/s41409-019-0703-1. Epub 2019 Sep 26.
7
Linking Complement Activation, Coagulation, and Neutrophils in Transplant-Associated Thrombotic Microangiopathy.在移植相关性血栓性微血管病中补体激活、凝血和中性粒细胞的关系。
Thromb Haemost. 2019 Sep;119(9):1433-1440. doi: 10.1055/s-0039-1692721. Epub 2019 Jul 2.
8
External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation.同种异体造血干细胞移植中多种预后评分的外部验证和比较。
Blood Adv. 2019 Jun 25;3(12):1881-1890. doi: 10.1182/bloodadvances.2019032268.
9
Complement in the Pathophysiology of the Antiphospholipid Syndrome.补体在抗磷脂综合征发病机制中的作用。
Front Immunol. 2019 Mar 14;10:449. doi: 10.3389/fimmu.2019.00449. eCollection 2019.
10
Hypertension in hematologic malignancies and hematopoietic cell transplantation: An emerging issue with the introduction of novel treatments.血液恶性肿瘤和造血细胞移植中的高血压：新型治疗方法引入带来的新问题。
Blood Rev. 2019 May;35:51-58. doi: 10.1016/j.blre.2019.03.003. Epub 2019 Mar 14.